Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity.

Infection and Immunity
Yi-Fang LiuJiunn-Jong Wu

Abstract

Outer membrane proteins (OMPs) serve as the permeability channels for nutrients, toxins, and antibiotics. In Escherichia coli, OmpA has been shown to be involved in bacterial virulence, and OmpC is related to multidrug resistance. However, it is unclear whether OmpC also has a role in the virulence of E. coli. The aims of this study were to characterize the role of OmpC in antimicrobial resistance and bacterial virulence in E. coli. The ompC deletion mutant showed significantly decreased susceptibility to carbapenems and cefepime. To investigate the survival of E. coli exposed to the innate immune system, a human blood bactericidal assay showed that the ompC mutant increased survival in blood and serum but not in complement-inactivated serum. These effects were also demonstrated in the natural selection of OmpC mutants. Also, C1q interacted with E. coli through a complex of antibodies bound to OmpC as a major target. Bacterial survival was increased in the wild-type strain in a dose-dependent manner by adding free recombinant OmpC protein or anti-C1q antibody to human serum. These results demonstrated that the interaction of OmpC-specific antibody and C1q was the key step in initiating the antibody-dependent classical pathway f...Continue Reading

References

Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S ForstM Inouye
Jan 1, 1986·Infection and Immunity·L A Joens, M E Nuessen
May 1, 1984·Infection and Immunity·N P SteeleR P Levine
Dec 1, 1995·Infection and Immunity·S P SinghT Abdullah
Apr 1, 1994·Infection and Immunity·J ErdeiA S Naidu
Mar 22, 2002·Biochemical and Biophysical Research Communications·Ying Wang
Nov 9, 2002·The Journal of Infectious Diseases·Kwang Sik Kim
Nov 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nemani V PrasadaraoLinette C Linsangan
Feb 15, 2003·Biochimica Et Biophysica Acta·Michael Bannwarth, Georg E Schulz
Oct 7, 2004·The Journal of Biological Chemistry·Johnson AgniswamyPeter D Sun
Apr 19, 2006·The Journal of Biological Chemistry·Takeshi YoshidaMasayori Inouye
Sep 5, 2006·Journal of Molecular Biology·Arnaud BasléTilman Schirmer
Feb 23, 2008·The Journal of Antimicrobial Chemotherapy·Yi-Fang LiuJiunn-Jong Wu
Feb 28, 2008·PloS One·Björn P JohanssonLars Björck
Aug 1, 1994·International Journal of Antimicrobial Agents·J O Capobianco, R C Goldman
Mar 10, 2010·The Journal of Antimicrobial Chemotherapy·Jiun-Han ChenFeng-Yee Chang
Aug 11, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Akira UkimuraUNKNOWN Clinical Research Committee on Myocarditis Associated with 2009 Influenza A (H1N1) Pandemic in Japan organized by Japanese C
Aug 12, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J J YanF C Yang
Sep 8, 2010·Nature Immunology·Scott B BergerCox Terhorst

❮ Previous
Next ❯

Citations

Nov 19, 2013·Omics : a Journal of Integrative Biology·Kubra KaraosmanogluBerna Sariyar Akbulut
Aug 22, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Eva TorresÁlvaro Pascual
Nov 28, 2015·Folia Microbiologica·D KohoutovaJ Bures
Jun 13, 2015·Journal of Proteomics·Cristian PirasPaola Roncada
Mar 30, 2016·Applied Microbiology and Biotechnology·Qingfeng GuanJianhua Wang
Mar 13, 2014·FEMS Microbiology Letters·Helen Miajlovic, Stephen G Smith
Jul 8, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jia DuTieli Zhou
May 10, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jeongjin Kim, Juhee Ahn
Apr 5, 2013·Clinical Microbiology Reviews·Alejandro BeceiroGermán Bou
Jul 28, 2019·Nature Communications·Zhi-Xue ChengXuan-Xian Peng
Aug 27, 2019·Frontiers in Microbiology·Carla Camprubí-FontMargarita Martinez-Medina
May 10, 2018·Frontiers in Microbiology·Gitanjali NandaKafleVolker S Brözel
Jan 20, 2019·Nature Communications·Daniel NicholJacob G Scott
Dec 4, 2019·Nature Reviews. Microbiology·Julia VergalliJean-Marie Pagès
Oct 24, 2020·Antibiotics·Virginio Cepas, Sara M Soto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.